Trials / Completed
CompletedNCT00962949
The Renin-Aldosterone Axis in Postural Tachycardia Syndrome
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- Vanderbilt University Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine the role of the renin-angiotensin-aldosterone in the pathophysiology of postural tachycardia syndrome, and to provide an insight about the disease process in this disorder.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Angiotensin II | Angiotensin II infusion for 1 hour |
Timeline
- Start date
- 2009-04-01
- Primary completion
- 2012-12-01
- Completion
- 2012-12-01
- First posted
- 2009-08-20
- Last updated
- 2025-09-16
- Results posted
- 2018-08-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00962949. Inclusion in this directory is not an endorsement.